Sample-size planning after an estimand change
Changing how a trial handles treatment discontinuation calls for revisiting its sample-size calculation. [Fang and Jin’s abstract](https://pubmed.ncbi.nlm.nih.gov/33821445/) describes approaches aligned with each of the five intercurrent-event strategies, including combinations, and explains why a conventional adjustment for missing data alone isn't estimand oriented.
4 karma2 comments